AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 294: G254-G262, 2008. First published November 8, 2007; doi:10.1152/ajpgi.00354.2007
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/G254    most recent
00354.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gill, R. K.
Right arrow Articles by Dudeja, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gill, R. K.
Right arrow Articles by Dudeja, P. K.

MUCOSAL BIOLOGY

Function, expression, and characterization of the serotonin transporter in the native human intestine

Ravinder K. Gill,1,* Nitika Pant,1 Seema Saksena,1 Amika Singla,1 Talat M. Nazir,2 Lisa Vohwinkel,2 Jerrold R. Turner,3 Jay Goldstein,1 Waddah A. Alrefai,1 and Pradeep K. Dudeja1,4,*

1Department of Medicine, University of Illinois at Chicago, 4Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois; 2Department of Pathology, University of Virginia Health System, Charlottesville, Virginia; and 3Department of Pathology, University of Chicago, Chicago, Illinois

Submitted 3 August 2007 ; accepted in final form 3 November 2007

The enteric serotonin transporter (SERT) plays a critical role in modulating serotonin availability and thus has been implicated in the pathogenesis of various intestinal disorders. To date, SERT expression and function in the human intestine have not been investigated. Current studies were designed to characterize the function, expression, distribution, and membrane localization of SERT in the native human intestine. Real-time PCR studies showed relatively higher SERT mRNA expression in the human small intestine compared with colon (ileum >> duodenum >> jejunum). Northern blot analysis revealed three mRNA hybridizing species encoding SERT (3.0, 4.9, and 6.8 kb) in the human ileum. Consistent with SERT mRNA expression, SERT immunostaining was mainly detected in the epithelial cells of human duodenal and ileal resected tissues. Notably, SERT expression was localized predominantly to the apical and intracellular compartments and was distributed throughout the crypt-villus axis. Immunoblotting studies detected a prominent protein band (~70 kDa) in the ileal apical plasma membrane vesicles (AMVs) isolated from mucosa obtained from organ-donor intestine. Functional studies showed that uptake of [3H]serotonin (150 nM) in human ileal AMVs was 1) significantly increased in the presence of both Na+ and Cl; 2) inhibited (~50%) by the neuronal SERT inhibitor, fluoxetine (10 µM) and by unlabeled 5-HT; and 3) exhibited saturation kinetics indicating the presence of a carrier-mediated process. Our studies demonstrated differential expression of SERT across various regions of the human intestine and provide evidence for the existence of a functional SERT capable of removing intraluminal serotonin in human ileal epithelial cells.

serotonin uptake; serotonin transporter expression



Address for reprint requests and other correspondence: R. K. Gill, Research Assistant Professor, Univ. of Illinois at Chicago, Jesse Brown V. A. Medical Center, Medical Research Service (600/151), 820 South Damen Ave., Chicago, IL 60612 (e-mail: rgill{at}uic.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.